FDA: Investigation into Multistate Salmonella Outbreak Linked to Jif Peanut Butter

FDA: Investigation into Multistate Salmonella Outbreak Linked to Jif Peanut Butter

• How long can the patient live after heart stent surgery?
• More than 500 new drugs for blood diseases are in development
• Keytruda: The 5-year survival rate for advanced lung cancer doubled!
• Amylyx released the latest statistical analysis of new ALS drugs after being opposed by FDA panel last month
• Celine Dion is paralyzed due to muscle cramps: What are Muscle Cramps?
• Taiwan death from COVID-19 vaccination exceeds death from COVID-19 
• The world top 5 best-selling drugs in 2020

FDA: Investigation into Multistate Salmonella Outbreak Linked to Jif Peanut Butter.

On May 21, The U.S. Food and Drug Administration (FDA) announced that it is investigating salmonella outbreaks in multiple states related to Jif peanut butter products.

The FDA said it has worked with the U.S. Centers for Disease Control and Prevention (CDC) and multiple local agencies to investigate JM. Peanut butter from the Smoke Company factory.

Citing the CDC, the FDA said the company’s product was “probably” the origin of five confirmed cases of salmonella infection, all of whom said they had eaten the brand’s peanut butter before falling ill.

It is reported that the FDA has issued a 2010 in Lexington, Kentucky JM. Whole-genome sequencing (WGS) analysis was performed on environmental samples collected at Smoke’s facilities.

Analysis showed that environmental samples from 2010 matched the disease-causing strains in this Salmonella outbreak.

Currently, JM. Smoke Co. has voluntarily recalled some of its Jif peanut butter products distributed across the U.S., warning consumers of a possible salmonella infection.

The company also announced that it will voluntarily recall several products sold in Canada due to potential safety risks.

(source:internet, reference only)

Disclaimer of medicaltrend.org